Hepatic saturated fatty acid fraction is associated with de novo lipogenesis and hepatic insulin resistance.
Ontology highlight
ABSTRACT: Hepatic steatosis is associated with poor cardiometabolic health, with de novo lipogenesis (DNL) contributing to hepatic steatosis and subsequent insulin resistance. Hepatic saturated fatty acids (SFA) may be a marker of DNL and are suggested to be most detrimental in contributing to insulin resistance. Here, we show in a cross-sectional study design (ClinicalTrials.gov ID: NCT03211299) that we are able to distinguish the fractions of hepatic SFA, mono- and polyunsaturated fatty acids in healthy and metabolically compromised volunteers using proton magnetic resonance spectroscopy (1H-MRS). DNL is positively associated with SFA fraction and is elevated in patients with non-alcoholic fatty liver and type 2 diabetes. Intriguingly, SFA fraction shows a strong, negative correlation w
SUBMITTER: Roumans KHM
PROVIDER: S-EPMC7170906 | biostudies-literature | 2020 Apr
REPOSITORIES: biostudies-literature
ACCESS DATA